Chile Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017

Summary

”Chile Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Chile Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Chile Diabetes Care Devicesmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Becton, Dickinson and Company, Abbott Laboratories, Bayer HealthCare AG, Novo Nordisk A/S and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Chile Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What is This Report About? 7
3 Diabetes Care Devices In Chile 8
3.1 Diabetes Care Devices, Chile, Overall Revenue ($m), USD Actual, 2003-2017 8
3.2 Diabetes Care Devices, Chile, Category Volume (Units), 2003-2017 12
3.3 Diabetes Care Devices, Chile, Company share (2009-2010) 15
4 Glucose Monitoring In Chile 17
4.1 Glucose Monitoring Overall Revenue (2003-2017) 17
4.1.1 Blood Glucose Meters Revenue (2003-2017) 21
4.2 Glucose Monitoring Overall Volume (2003-2017) 23
4.2.1 Blood Glucose Meters Volume (2003-2017) 26
4.3 Glucose Monitoring Average Price (2003-2017) 28
4.4 Glucose Monitoring Distribution Share (2009-2010) 29
4.5 Glucose Monitoring, Chile, Company share (2009-2010) 30
5 Insulin Delivery In Chile 31
5.1 Insulin Delivery Overall Revenue (2003-2017) 31
5.1.1 Insulin Pens Revenue (2003-2017) 35
5.1.2 Insulin Pumps Revenue (2003-2017) 39
5.2 Insulin Delivery Overall Volume (2003-2017) 41
5.2.1 Insulin Pens Volume (2003-2017) 45
5.2.2 Insulin Pumps Volume (2003-2017) 49
5.3 Insulin Delivery Average Price (2003-2017) 51
5.4 Insulin Delivery Distribution Share (2009-2010) 52
5.5 Insulin Delivery, Chile, Company share (2009-2010) 53
6 Overview of Key Companies in Chile Diabetes Care Devices Market 55
6.1 F. Hoffmann-La Roche Ltd. 55
6.1.1 Company Overview 55
6.2 LifeScan, Inc. 55
6.2.1 Company Overview 55
6.3 Becton, Dickinson and Company 55
6.3.1 Company Overview 55
6.4 Abbott Laboratories 56
6.4.1 Company Overview 56
6.5 Bayer HealthCare AG 56
6.5.1 Company Overview 56
6.6 Novo Nordisk A/S 56
6.6.1 Company Overview 56
6.7 Sanofi 57
6.7.1 Company Overview 57
6.8 Eli Lilly and Company 57
6.8.1 Company Overview 57
6.9 NIPRO CORPORATION 57
6.9.1 Company Overview 57
7 APPENDIX 58
7.1 Global Markets Direct Research Methodology 58
7.2 Definitions of Markets Covered in the Report 59
7.2.1 Diabetes Care Devices 59
7.3 Secondary Research 62
7.4 Primary Research 62
7.5 Models 63
7.6 Forecasts 63
7.7 Expert Panel Validation 63
7.8 Currency Conversion 64
7.9 Contact Us 64
7.10 Disclaimer 64

1.1 List of Tables
Table 1: Diabetes Care Devices, Chile, Overall Revenue ($m), USD Actual, 2003-2017 8
Table 2: Diabetes Care Devices, Chile, Overall Revenue ($m), USD Actual, Historic, 2003-2010 9
Table 3: Diabetes Care Devices, Chile, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 11
Table 4: Diabetes Care Devices, Chile, Category Volume (Units), 2003-2017 12
Table 5: Diabetes Care Devices, Chile, Category Volume (Units), Historic, 2003-2010 13
Table 6: Diabetes Care Devices, Chile, Category Volume (Units), Forecast, 2010-2017 14
Table 7: Diabetes Care Devices, Chile, Company share by Revenue ($m), USD Actual, 2009-2010 16
Table 8: Glucose Monitoring, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 18
Table 9: Glucose Monitoring, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 20
Table 10: Blood Glucose Meters (Traditional Glucose Meters), Chile, Revenue ($m), USD Actual, Historic, 2003-2010 21
Table 11: Blood Glucose Meters (Traditional Glucose Meters), Chile, Revenue ($m), USD Actual,Forecast, 2010-2017 22
Table 12: Glucose Monitoring, Chile, Volume (Units) by Segment, Historic, 2003-2010 24
Table 13: Glucose Monitoring, Chile, Volume (Units) by Segment, Forecast, 2010-2017 25
Table 14: Blood Glucose Meters (Traditional Glucose Meters), Chile, Volume (Units), Historic, 2003-2010 26
Table 15: Blood Glucose Meters (Traditional Glucose Meters), Chile, Volume (Units), Forecast, 2010-2017 27
Table 16: Glucose Monitoring, Chile, Average Price ($), Historic, 2003-2010 28
Table 17: Glucose Monitoring, Chile, Average Price ($), Forecast, 2010-2017 28
Table 18: Glucose Monitoring, Chile, Distribution Share by Revenue ($m), USD Actual, 2009-2010 29
Table 19: Glucose Monitoring, Chile, Company share by Revenue ($m), USD Actual 2009-2010 30
Table 20: Insulin Delivery, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 32
Table 21: Insulin Delivery, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 34
Table 22: Insulin Pens, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 36
Table 23: Insulin Pens, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 38
Table 24: Insulin Pumps (Traditional Insulin Pumps), Chile, Revenue ($m), USD Actual, Historic, 2003-2010 39
Table 25: Insulin Pumps (Traditional Insulin Pumps), Chile, Revenue ($m), USD Actual, Forecast, 2010-2017 40
Table 26: Insulin Delivery, Chile, Volume (Units) by Segment, Historic, 2003-2010 42
Table 27: Insulin Delivery, Chile, Volume (Units) by Segment, Forecast, 2010-2017 44
Table 28: Insulin Pens, Chile, Volume (Units) by Sub-Segment, Historic, 2003-2010 46
Table 29: Insulin Pens, Chile, Volume (Units) by Sub-Segment, Forecast, 2010-2017 48
Table 30: Insulin Pumps (Traditional Insulin Pumps), Chile, Volume (Units), Historic, 2003-2010 49
Table 31: Insulin Pumps (Traditional Insulin Pumps), Chile, Volume (Units), Forecast, 2010-2017 50
Table 32: Insulin Delivery, Chile, Average Price ($), Historic, 2003-2010 51
Table 33: Insulin Delivery, Chile, Average Price ($), Forecast, 2010-2017 51
Table 34: Insulin Delivery, Chile, Distribution Share by Revenue ($m), USD Actual, 2009-2010 52
Table 35: Insulin Delivery, Chile, Company share by Revenue ($m), USD Actual 2009-2010 54
Table 36: USD to Local Currency, Chile, Average Actual Rate 2003-2010 64

1.2 List of Figures
Figure 1: Diabetes Care Devices, Chile, Overall Revenue ($m), USD Actual, 2003-2017 8
Figure 2: Diabetes Care Devices, Chile, Overall Revenue ($m), USD Actual, Historic, 2003-2010 9
Figure 3: Diabetes Care Devices, Chile, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 10
Figure 4: Diabetes Care Devices, Chile, Category Volume (Units), 2003-2017 12
Figure 5: Diabetes Care Devices, Chile, Category Volume (Units), Historic, 2003-2010 13
Figure 6: Diabetes Care Devices, Chile, Category Volume (Units), Forecast, 2010-2017 14
Figure 7: Diabetes Care Devices, Chile, Company share (%), 2010 15
Figure 8: Glucose Monitoring, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 17
Figure 9: Glucose Monitoring, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 19
Figure 10: Blood Glucose Meters (Traditional Glucose Meters), Chile, Revenue ($m), USD Actual, Historic, 2003-2010 21
Figure 11: Blood Glucose Meters (Traditional Glucose Meters), Chile, Revenue ($m), USD Actual, Forecast, 2010-2017 22
Figure 12: Glucose Monitoring, Chile, Volume (Units) by Segment, Historic, 2003-2010 23
Figure 13: Glucose Monitoring, Chile, Volume (Units) by Segment, Forecast, 2010-2017 25
Figure 14: Blood Glucose Meters (Traditional Glucose Meters), Chile, Volume (Units) Historic, 2003-2010 26
Figure 15: Blood Glucose Meters (Traditional Glucose Meters), Chile, Volume (Units) Forecast, 2010-2017 27
Figure 16: Glucose Monitoring, Chile, Company share (%), 2010 30
Figure 17: Insulin Delivery, Chile, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 31
Figure 18: Insulin Delivery, Chile, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 33
Figure 19: Insulin Pens, Chile, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 35
Figure 20: Insulin Pens, Chile, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 37
Figure 21: Insulin Pumps (Traditional Insulin Pumps), Chile, Revenue ($m), USD Actual, Historic, 2003-2010 39
Figure 22: Insulin Pumps (Traditional Insulin Pumps), Chile, Revenue ($m), USD Actual, Forecast, 2010-2017 40
Figure 23: Insulin Delivery, Chile, Volume (Units) by Segment, Historic, 2003-2010 41
Figure 24: Insulin Delivery, Chile, Volume (Units) by Segment, Forecast, 2010-2017 43
Figure 25: Insulin Pens, Chile, Volume (Units) by Sub-Segment, Historic, 2003-2010 45
Figure 26: Insulin Pens, Chile, Volume (Units) by Sub-Segment, Forecast, 2010-2017 47
Figure 27: Insulin Pumps (Traditional Insulin Pumps), Chile, Volume (Units), Historic, 2003-2010 49
Figure 28: Insulin Pumps (Traditional Insulin Pumps), Chile, Volume (Units), Forecast, 2010-2017 50
Figure 29: Insulin Delivery, Chile, Company share (%), 2010 53
Figure 30: Global Markets Direct Methodology 58

Companies Mentioned

F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Becton, Dickinson and Company
Abbott Laboratories
Bayer HealthCare AG
Novo Nordisk A/S
Sanofi
Eli Lilly and Company
NIPRO CORPORATION